Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study.

[1]  R. Gutzmer,et al.  Comparison of classification systems in melanoma sentinel lymph nodes—An analysis of 697 patients from a single center , 2010, Cancer.

[2]  C. Garbe,et al.  Melanoma staging: facts and controversies. , 2010, Clinics in dermatology.

[3]  S. Meterissian,et al.  Validation Study of the S Classification for Melanoma Patients with Positive Sentinel Nodes: The Montreal Experience , 2010, Annals of Surgical Oncology.

[4]  S. Gambhir,et al.  Reply to: The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanoma , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Mihm,et al.  Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden. , 2009, European journal of cancer.

[7]  I. V. D. van der Ploeg,et al.  Comparison of Three Micromorphometric Pathology Classifications of Melanoma Metastases in the Sentinel Node , 2009, Annals of surgery.

[8]  M. Smylie,et al.  Prediction of nonsentinel lymph node metastasis in malignant melanoma. , 2009, The Journal of surgical research.

[9]  I. V. D. van der Ploeg,et al.  Is Completion Lymph Node Dissection Needed in Case of Minimal Melanoma Metastasis in the Sentinel Node? , 2009, Annals of surgery.

[10]  Jeffrey E. Lee,et al.  Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  K. Griffith,et al.  Do Micromorphometric Features of Metastatic Deposits Within Sentinel Nodes Predict Nonsentinel Lymph Node Involvement in Melanoma? , 2008, Annals of Surgical Oncology.

[12]  S. Di Palma,et al.  Pathology of sentinel lymph nodes for melanoma , 2008, Journal of Clinical Pathology.

[13]  R. Dummer,et al.  The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma – a retrospective analysis of 392 cases , 2008, British Journal of Cancer.

[14]  R. Gutzmer,et al.  Criteria in Sentinel Lymph Nodes of Melanoma Patients that Predict Involvement of Nonsentinel Lymph Nodes , 2008, Annals of Surgical Oncology.

[15]  S. Mocellin,et al.  Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node , 2008, Annals of Surgical Oncology.

[16]  A. Eggermont,et al.  Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  R. Elashoff,et al.  Sentinel-node biopsy or nodal observation in melanoma. , 2006, The New England journal of medicine.

[18]  Jennifer L. Schwartz,et al.  Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. , 2005, Journal of the American College of Surgeons.

[19]  D. Morton,et al.  Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Green,et al.  The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Scolyer,et al.  Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens , 2004, Melanoma research.

[22]  R. Elashoff,et al.  Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node , 2004, Modern Pathology.

[23]  B. Balda,et al.  Sentinel lymphonodectomy and S-classification: A successful strategy for better prediction and improvement of outcome of melanoma , 2004, Annals of Surgical Oncology.

[24]  G. Salti,et al.  Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases. , 2003, American journal of surgery.

[25]  R. Lyles,et al.  The Amount of Metastatic Melanoma in a Sentinel Lymph Node: Does It Have Prognostic Significance? , 2003, Annals of Surgical Oncology.

[26]  J. J. Coleman,et al.  Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy , 2002, Annals of Surgical Oncology.

[27]  A. Halpern,et al.  Guidelines of care for primary cutaneous melanoma. , 2001, Journal of the American Academy of Dermatology.

[28]  Hong Wang,et al.  A micromorphometry‐based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma , 2001, Cancer.

[29]  M. Ross,et al.  Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[31]  H. Hoekstra,et al.  Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. , 1992, Archives of surgery.

[32]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[33]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[34]  M. Binder,et al.  Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  P. Carli,et al.  Italian guidelines for staging and follow-up of stage I-II cutaneous melanoma patients , 2007 .

[36]  D. Morton,et al.  The role of sentinel lymph node biopsy in the management of melanoma. , 2007, Advances in surgery.

[37]  M. Ross,et al.  Frequency of nonsentinel lymph node metastasis in melanoma , 2007, Annals of Surgical Oncology.

[38]  D. Coit,et al.  Prediction of Nonsentinel Lymph Node Status in Melanoma , 2003, Annals of Surgical Oncology.

[39]  H. Shaw,et al.  Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma , 2002, Cancer.